Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl PCDFs

dc.creator	Safe, Stephen H.
dc.date.accessioned	2019-06-17T16:55:37Z
dc.date.available	2019-06-17T16:55:37Z
dc.date.issued	2000-10-24
dc.identifier.uri	https://hdl.handle.net/1969.1/176647
dc.description.abstract	Methods and pharmaceutical combinations for inhibiting estrogen-dependent tumors via the co-administration of antiestrogen triphenylethylenes, including tamoxifen, and alkyl PCDFs.	en
dc.language	eng
dc.publisher	United States. Patent and Trademark Office
dc.rights	Public Domain (No copyright - United States)	en
dc.rights.uri	http://rightsstatements.org/vocab/NoC-US/1.0/
dc.title	Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl PCDFs	en
dc.type	Utility patent	en
dc.format.digitalOrigin	reformatted digital	en
dc.description.country	US
dc.contributor.assignee	The Texas A&M University System
dc.identifier.patentapplicationnumber	09/217780
dc.subject.uspcprimary	514/443
dc.subject.uspcother	514/648
dc.date.filed	1998-12-21
dc.publisher.digital	Texas A&M University. Libraries
dc.subject.cpcprimary	A61P 35/00
dc.subject.cpcprimary	A61P 5/32
dc.subject.cpcprimary	A61P 43/00
dc.subject.cpcprimary	A61K 45/06
dc.subject.cpcprimary	A61K 31/343
dc.subject.cpcprimary	A61K 2300/00